Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.5389 +0.0071 (+1.34%)

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Heartbeam, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 16, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

September 16, 2022

We're starting off the final trading day of the week with a look at the biggest pre-market stock movers for Friday and what's moving them!

Via InvestorPlace

Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket ↗

September 16, 2022

Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) rose 159.4% to $25.94 in pre-market trading after gaining 11% on Thursday.

Via Benzinga

Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday ↗

September 16, 2022

Gainers

Via Benzinga

S&P 500 Down 0.6%; Crude Oil Falls Sharply ↗

September 15, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 15, 2022

Via Benzinga

What Is Going on With HeartBeam (BEAT) Stock Today? ↗

September 15, 2022

HeartBeam (BEAT) stock is rocketing higher on heavy trading Thursday as investors react to news of a new heart monitor patent.

Via InvestorPlace

Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session ↗

September 15, 2022

Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome...

Via Benzinga

Looking Into BioTelemetry's Recent Short Interest ↗

September 15, 2022

BioTelemetry's (NASDAQ:BEAT) short percent of float has risen 25.93% since its last report. The company recently reported that it has 65 thousand shares sold short, which is 1.02...

Via Benzinga

US Stocks Turn Lower; Nasdaq Drops Over 100 Points ↗

September 15, 2022

U.S. stocks turned lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Thursday.

Via Benzinga

BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures Additional IP Protection for Breakthrough ECG Patch Technology

September 15, 2022

Via Investor Brand Network

Topics Intellectual Property

Why Heartbeam Shares Are Skyrocketing 75% Higher ↗

September 15, 2022

Heartbeam Inc (NASDAQ: BEAT) shares are trading higher by 76% to $2.20 Thursday morning after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of...

Via Benzinga

HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias

September 15, 2022

From HeartBeam, Inc.

Via Business Wire

BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Unveil Platform Technology in Virtual Roadshow Webinar

September 12, 2022

Via Investor Brand Network

Topics Credit Cards

HeartBeam to Host Virtual Roadshow Webinar on Tuesday September 20, 2022 at 4:30 p.m. Eastern Time

September 12, 2022

From HeartBeam, Inc.

Via Business Wire

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 16, 2022

Via Benzinga

HeartBeam Announces FDA Submission of HeartBeam AIMI™ Product

August 16, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam Reports Second Quarter 2022 Financial Results

August 11, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam Names Ken Persen as Chief Technology Officer

August 04, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam Wins CVI 2022 Innovation Summit Award

July 28, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam to Host Second Quarter 2022 Results Conference Call on Thursday August 11, 2022 at 4:30 p.m. Eastern Time

July 26, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam Expands Patient Population for Emergency Department Software Technology Solution

June 30, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022

May 25, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022

May 18, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam Reports First Quarter 2022 Financial Results

May 12, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam to Host First Quarter 2022 Results Conference Call on Thursday May 12, 2022 at 4:30 p.m. Eastern Time

April 28, 2022

From HeartBeam, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 21, 2022

Gainers

Via Benzinga

66 Biggest Movers From Yesterday ↗

May 03, 2022

Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...

Via Benzinga

HeartBeam to Host Virtual Roadshow Webinar on Wednesday April 27, 2022 at 11:30 a.m. Eastern Time

April 19, 2022

From HeartBeam, Inc.

Via Business Wire

HeartBeam Reports Fourth Quarter and Full Year 2021 Financial Results

March 24, 2022

From HeartBeam, Inc.

Via Business Wire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.